Email correspondence – COVID-19 Mortality data
ATAGI Statement – Revised recommendations on the use of COVID-19 Vaccine AstraZeneca
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
The documents include correspondence containing data on COVID-19 mortality by age group, and an ATAGI statement regarding the use of COVID-19 Vaccine AstraZeneca.